China Pharma Holdings (CPHI) Revenue (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Revenue came in at $983536.0 in Q1 2026, down 13.44% YoY from $1.1 million in Q1 2025, and down 19.78% on a QoQ basis from $1.2 million in Q4 2025.
China Pharma Holdings (CPHI) Revenue (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Revenue data on file, last reported at $983536.0 in Q1 2026.
- Quarterly Revenue fell 13.44% year-over-year to $983536.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 7.07% YoY) and the FY2025 annual result came in at $4.1 million, down 8.49% from the prior year.
- Revenue eased to $983536.0 in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $2.9 million in Q4 2022 to a low of $756217.0 in Q3 2025.
- A 5-year average of $1.5 million and a median of $1.2 million in 2025 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue climbed 22.21% — and 2024, when it sank 47.25%.
- Tracing CPHI's Revenue over 5 years: stood at $2.9 million in 2022, then fell by 26.41% to $2.1 million in 2023, then tumbled by 47.25% to $1.1 million in 2024, then advanced by 8.11% to $1.2 million in 2025, then declined by 19.78% to $983536.0 in 2026.
- The last three Revenue figures came in at $983536.0 (Q1 2026), $1.2 million (Q4 2025), and $756217.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.35 Mn | 42.04 Mn | 83,566.00 | 948,340.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 983,536.00 |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 756,217.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 924,943.00 |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | 2.92 Mn |
| Sep 30, 2022 | 1.97 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 1.98 Mn |
| Jun 30, 2021 | 2.42 Mn |